In its effort to rival GSK’s shingles vaccine Shingrix, Curevo Vaccine has circled up $110 million and recruited two former ...
Moncef Slaoui, who ran the Operation Warp Speed Covid vaccine effort, is becoming chair of Curevo, a company developing a new ...
Eli Lilly CEO Dave Ricks made $114 million last year, according to a new proxy statement, a rare instance of a health ...
Viruses like the one that causes COVID-19 constantly mutate, rendering many antibody treatments ineffective. A Stanford-led ...
GlobalData on MSN1d
Curevo attains $110m and former-GSK exec for shingles vaccine candidateCurevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former executive from the UK big pharma to advance its candidate amezosvatein.
GSK and Lilly representatives decline to comment. In emails to Klimas and C&EN, Regeneron staff cite the need for "robust," "objective criteria" before the company’s COVID-19 antibody REGEN-COV ...
MedPage Today on MSN9d
Can Flu Shot Nudges Lead to Fewer COVID Vaccinations?Receiving an electronic reminder about influenza vaccination appeared to decrease COVID vaccination rates. Further study of ...
All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback